$19.5M Abilify Improper Marketing Settlement Obtained by 43 States
States Allege BMS Marketed Abilify Antipsychotic to Children, Elderly. In a multistate settlement, Bristol-Myers Squibb agreed to pay $19.5 million to settle allegations of improper marketing with its atypical [...]